Most Liquid Health Care Equipment & Supplies Companies

Cash And Equivalents
Cash And EquivalentsEfficiencyMarket RiskExp Return
1ABT Abbott Laboratories
7.62 B
(0.06)
 1.01 
(0.06)
2ISRG Intuitive Surgical
4.32 B
 0.08 
 2.43 
 0.18 
3SYK Stryker
3.65 B
(0.08)
 1.15 
(0.10)
4ADVB Advanced Biomed Common
3.05 B
 0.06 
 7.29 
 0.43 
5EW Edwards Lifesciences Corp
3.05 B
 0.04 
 1.28 
 0.05 
6PHG Koninklijke Philips NV
2.4 B
 0.03 
 1.38 
 0.04 
7HOLX Hologic
2.39 B
 0.09 
 1.60 
 0.14 
8DXCM DexCom Inc
2.37 B
(0.12)
 2.98 
(0.37)
9MDT Medtronic PLC
2.22 B
 0.03 
 1.16 
 0.04 
10DHR Danaher
2.08 B
 0.08 
 2.04 
 0.16 
11GEHC GE HealthCare Technologies
1.85 B
 0.06 
 1.69 
 0.11 
12BAX Baxter International
1.76 B
(0.10)
 2.58 
(0.25)
13BDX Becton Dickinson and
1.72 B
 0.01 
 1.68 
 0.02 
14RMD ResMed Inc
1.21 B
(0.20)
 1.20 
(0.24)
15ALGN Align Technology
1.09 B
 0.01 
 2.15 
 0.02 
16ALC Alcon AG
1.03 B
(0.13)
 1.92 
(0.25)
17NVCR Novocure
948.52 M
 0.06 
 2.80 
 0.17 
18PODD Insulet
708.6 M
 0.08 
 1.89 
 0.15 
19TNDM Tandem Diabetes Care
608.73 M
(0.01)
 4.68 
(0.04)
20AMWL American Well Corp
581.61 M
(0.11)
 3.59 
(0.40)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes. Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).